{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T08:43:30Z","timestamp":1776588210223,"version":"3.51.2"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007847","name":"Natural Science Foundation of Jilin Province","doi-asserted-by":"publisher","award":["20180101237JC"],"award-info":[{"award-number":["20180101237JC"]}],"id":[{"id":"10.13039\/100007847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013064","name":"Key Research and Development Program of Jiangxi Province","doi-asserted-by":"publisher","award":["20170204025YY"],"award-info":[{"award-number":["20170204025YY"]}],"id":[{"id":"10.13039\/501100013064","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.lfs.2023.122131","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T06:03:18Z","timestamp":1695967398000},"page":"122131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Synergistic lethality between auranofin-induced oxidative DNA damage and ATR inhibition in cancer cells"],"prefix":"10.1016","volume":"332","author":[{"given":"Shan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ce","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jialiang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihua","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.lfs.2023.122131_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12082098","article-title":"DNA damage-inducing anticancer therapies: from global to precision damage","volume":"12","author":"Reuvers","year":"2020","journal-title":"Cancers"},{"issue":"7267","key":"10.1016\/j.lfs.2023.122131_bb0010","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nature08467","article-title":"The DNA-damage response in human biology and disease","volume":"461","author":"Jackson","year":"2009","journal-title":"Nature."},{"issue":"2","key":"10.1016\/j.lfs.2023.122131_bb0015","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.molcel.2010.09.019","article-title":"The DNA damage response: making it safe to play with knives","volume":"40","author":"Ciccia","year":"2010","journal-title":"Mol. Cell"},{"issue":"6","key":"10.1016\/j.lfs.2023.122131_bb0020","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.molcel.2017.05.015","article-title":"ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response","volume":"66","author":"Blackford","year":"2017","journal-title":"Mol. Cell"},{"issue":"Suppl. 7","key":"10.1016\/j.lfs.2023.122131_bb0025","doi-asserted-by":"crossref","first-page":"vii115","DOI":"10.1093\/annonc\/mdl963","article-title":"Apoptosis: a relevant tool for anticancer therapy","volume":"17","author":"Russo","year":"2006","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"issue":"2","key":"10.1016\/j.lfs.2023.122131_bb0030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.canlet.2012.01.007","article-title":"DNA damage-induced cell death: from specific DNA lesions to the DNA damage response and apoptosis","volume":"332","author":"Roos","year":"2013","journal-title":"Cancer Lett."},{"issue":"9","key":"10.1016\/j.lfs.2023.122131_bb0035","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nrc3342","article-title":"The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance","volume":"12","author":"Bouwman","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.lfs.2023.122131_bb0040","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2015.2","article-title":"DNA damage and the balance between survival and death in cancer biology","volume":"16","author":"Roos","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lfs.2023.122131_bb0045","doi-asserted-by":"crossref","first-page":"215804","DOI":"10.1016\/j.canlet.2022.215804","article-title":"Mechanisms used by cancer cells to tolerate drug-induced replication stress","volume":"544","author":"Segeren","year":"2022","journal-title":"Cancer Lett."},{"issue":"7381","key":"10.1016\/j.lfs.2023.122131_bb0050","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nature10760","article-title":"The DNA damage response and cancer therapy","volume":"481","author":"Lord","year":"2012","journal-title":"Nature."},{"issue":"9","key":"10.1016\/j.lfs.2023.122131_bb0055","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201846263","article-title":"Mechanisms for stalled replication fork stabilization: new targets for synthetic lethality strategies in cancer treatments","volume":"19","author":"Liao","year":"2018","journal-title":"EMBO Rep."},{"issue":"11","key":"10.1016\/j.lfs.2023.122131_bb0060","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41576-020-0247-7","article-title":"Discovering and validating cancer genetic dependencies: approaches and pitfalls","volume":"21","author":"Lin","year":"2020","journal-title":"Nat. Rev. Genet."},{"issue":"4","key":"10.1016\/j.lfs.2023.122131_bb0065","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.molcel.2015.10.040","article-title":"Targeting the DNA damage response in cancer","volume":"60","author":"O\u2019Connor","year":"2015","journal-title":"Mol. Cell"},{"issue":"11","key":"10.1016\/j.lfs.2023.122131_bb0070","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1158\/1535-7163.MCT-13-0136","article-title":"Contribution of ATM and ATR to the resistance of glioblastoma and malignant melanoma cells to the methylating anticancer drug temozolomide","volume":"12","author":"Eich","year":"2013","journal-title":"Mol. Cancer Ther."},{"issue":"13","key":"10.1016\/j.lfs.2023.122131_bb0075","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1158\/1078-0432.CCR-13-3229","article-title":"Molecular pathways: overcoming radiation resistance by targeting DNA damage response pathways","volume":"21","author":"Morgan","year":"2015","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"issue":"2","key":"10.1016\/j.lfs.2023.122131_bb0080","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41568-022-00535-5","article-title":"Targeting DNA damage response pathways in cancer","volume":"23","author":"Groelly","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.lfs.2023.122131_bb0085","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41571-018-0114-z","article-title":"State-of-the-art strategies for targeting the DNA damage response in cancer","volume":"16","author":"Pili\u00e9","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.lfs.2023.122131_bb0090","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41573-022-00558-5","article-title":"Targeting replication stress in cancer therapy","volume":"22","author":"da Costa","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"18","key":"10.1016\/j.lfs.2023.122131_bb0095","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019101801","article-title":"DNA damage kinase signaling: checkpoint and repair at 30 years","volume":"38","author":"Lanz","year":"2019","journal-title":"EMBO J."},{"issue":"10","key":"10.1016\/j.lfs.2023.122131_bb0100","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrm.2017.67","article-title":"The essential kinase ATR: ensuring faithful duplication of a challenging genome","volume":"18","author":"Saldivar","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"10","key":"10.1016\/j.lfs.2023.122131_bb0105","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1016\/j.celrep.2018.08.019","article-title":"ATR-mediated global fork slowing and reversal assist fork traverse and prevent chromosomal breakage at DNA interstrand cross-links","volume":"24","author":"Mutreja","year":"2018","journal-title":"Cell Reports"},{"issue":"27","key":"10.1016\/j.lfs.2023.122131_bb0110","doi-asserted-by":"crossref","first-page":"13374","DOI":"10.1073\/pnas.1903418116","article-title":"An ATR and CHK1 kinase signaling mechanism that limits origin firing during unperturbed DNA replication","volume":"116","author":"Moiseeva","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2023.122131_bb0115","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41580-021-00404-3","article-title":"Cell cycle control in cancer","volume":"23","author":"Matthews","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.lfs.2023.122131_bb0120","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.tibs.2020.11.002","article-title":"The hammer and the dance of cell cycle control","volume":"46","author":"Panagopoulos","year":"2021","journal-title":"Trends Biochem. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2023.122131_bb0125","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1535-6108(03)00048-5","article-title":"Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A","volume":"3","author":"S\u00f8rensen","year":"2003","journal-title":"Cancer Cell"},{"issue":"5\u20136","key":"10.1016\/j.lfs.2023.122131_bb0130","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.drudis.2011.12.009","article-title":"Targeting the S and G2 checkpoint to treat cancer","volume":"17","author":"Chen","year":"2012","journal-title":"Drug Discov. Today"},{"issue":"4","key":"10.1016\/j.lfs.2023.122131_bb0135","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.celrep.2013.10.027","article-title":"ATR activates the S-M checkpoint during unperturbed growth to ensure sufficient replication prior to mitotic onset","volume":"5","author":"Eykelenboom","year":"2013","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.lfs.2023.122131_bb0140","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.cell.2013.10.043","article-title":"ATR prohibits replication catastrophe by preventing global exhaustion of RPA","volume":"155","author":"Toledo","year":"2013","journal-title":"Cell."},{"issue":"6","key":"10.1016\/j.lfs.2023.122131_bb0145","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.molcel.2017.05.001","article-title":"Replication catastrophe: when a checkpoint fails because of exhaustion","volume":"66","author":"Toledo","year":"2017","journal-title":"Mol. Cell"},{"issue":"9","key":"10.1016\/j.lfs.2023.122131_bb0150","doi-asserted-by":"crossref","first-page":"108096","DOI":"10.1016\/j.celrep.2020.108096","article-title":"ATR restrains DNA synthesis and mitotic catastrophe in response to CDC7 inhibition","volume":"32","author":"Rainey","year":"2020","journal-title":"Cell Rep."},{"issue":"23","key":"10.1016\/j.lfs.2023.122131_bb0155","doi-asserted-by":"crossref","first-page":"9693","DOI":"10.1158\/0008-5472.CAN-10-2286","article-title":"Combining ATR suppression with oncogenic Ras synergistically increases genomic instability, causing synthetic lethality or tumorigenesis in a dosage-dependent manner","volume":"70","author":"Gilad","year":"2010","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.lfs.2023.122131_bb0160","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/nsmb.2189","article-title":"Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors","volume":"18","author":"Murga","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"1","key":"10.1016\/j.lfs.2023.122131_bb0165","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1172\/JCI58928","article-title":"Oncogenic stress sensitizes murine cancers to hypomorphic suppression of ATR","volume":"122","author":"Schoppy","year":"2012","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.lfs.2023.122131_bb0170","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ccell.2021.02.014","article-title":"Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress","volume":"39","author":"Thomas","year":"2021","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.lfs.2023.122131_bb0175","doi-asserted-by":"crossref","first-page":"100394","DOI":"10.1016\/j.xcrm.2021.100394","article-title":"CCNE1 copy number is a biomarker for response to combination WEE1-ATR inhibition in ovarian and endometrial cancer models","volume":"2","author":"Xu","year":"2021","journal-title":"Cell Rep. Med."},{"issue":"1","key":"10.1016\/j.lfs.2023.122131_bb0180","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1158\/2159-8290.CD-20-0868","article-title":"First-in-human trial of the oral ataxia telangiectasia and RAD3-related (ATR) inhibitor BAY 1895344 in patients with advanced solid tumors","volume":"11","author":"Yap","year":"2021","journal-title":"Cancer Discov."},{"issue":"19","key":"10.1016\/j.lfs.2023.122131_bb0185","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1158\/1078-0432.CCR-21-1032","article-title":"Ceralasertib (AZD6738), an oral ATR kinase inhibitor, in combination with carboplatin in patients with advanced solid tumors: a phase I study","volume":"27","author":"Yap","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.lfs.2023.122131_bb0190","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1158\/1535-7163.MCT-21-0615","article-title":"RP-3500: a novel, potent, and selective ATR inhibitor that is effective in preclinical models as a monotherapy and in combination with PARP inhibitors","volume":"21","author":"Roulston","year":"2022","journal-title":"Mol. Cancer Ther."},{"issue":"6","key":"10.1016\/j.lfs.2023.122131_bb0195","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1158\/0008-5472.CAN-21-2997","article-title":"ATR inhibitor AZD6738 (ceralasertib) exerts antitumor activity as a monotherapy and in combination with chemotherapy and the PARP inhibitor olaparib","volume":"82","author":"Wilson","year":"2022","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.lfs.2023.122131_bb0200","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1158\/1078-0432.CCR-20-3358","article-title":"The challenge of combining chemo- and radiotherapy with checkpoint kinase inhibitors","volume":"27","author":"van Bijsterveldt","year":"2021","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"issue":"2","key":"10.1016\/j.lfs.2023.122131_bb0205","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ccell.2014.11.019","article-title":"Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression","volume":"27","author":"Harris","year":"2015","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.lfs.2023.122131_bb0210","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.105","article-title":"ROS homeostasis and metabolism: a dangerous liason in cancer cells","volume":"7","author":"Panieri","year":"2016","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.lfs.2023.122131_bb0215","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrc3803","article-title":"Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles\u2019 heel?","volume":"14","author":"Sabharwal","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lfs.2023.122131_bb0220","doi-asserted-by":"crossref","first-page":"610205","DOI":"10.3389\/fphar.2020.610205","article-title":"Alkannin-induced oxidative DNA damage synergizes with PARP inhibition to cause cancer-specific cytotoxicity","volume":"11","author":"Chang","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.lfs.2023.122131_bb0225","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.tibs.2019.01.001","article-title":"Targeting metabolic-redox circuits for cancer therapy","volume":"44","author":"Wang","year":"2019","journal-title":"Trends Biochem. Sci."},{"issue":"14","key":"10.1016\/j.lfs.2023.122131_bb0230","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1038\/s41388-020-1191-x","article-title":"Synergistic lethality between PARP-trapping and alantolactone-induced oxidative DNA damage in homologous recombination-proficient cancer cells","volume":"39","author":"Wang","year":"2020","journal-title":"Oncogene."},{"issue":"3","key":"10.1016\/j.lfs.2023.122131_bb0235","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/med.21872","article-title":"Upgrade of an old drug: Auranofin in innovative cancer therapies to overcome drug resistance and to increase drug effectiveness","volume":"42","author":"Gamberi","year":"2022","journal-title":"Med. Res. Rev."},{"issue":"22","key":"10.1016\/j.lfs.2023.122131_bb0240","doi-asserted-by":"crossref","first-page":"35728","DOI":"10.18632\/oncotarget.16113","article-title":"Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.lfs.2023.122131_bb0245","doi-asserted-by":"crossref","first-page":"101949","DOI":"10.1016\/j.redox.2021.101949","article-title":"Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer","volume":"42","author":"Freire Boullosa","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.lfs.2023.122131_bb0250","doi-asserted-by":"crossref","first-page":"101491","DOI":"10.1016\/j.redox.2020.101491","article-title":"Comprehensive chemical proteomics for target deconvolution of the redox active drug auranofin","volume":"32","author":"Saei","year":"2020","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.lfs.2023.122131_bb0255","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41416-021-01332-x","article-title":"Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofin","volume":"125","author":"Karsa","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"16","key":"10.1016\/j.lfs.2023.122131_bb0260","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27165207","article-title":"Anti-cancer effects of auranofin in human lung cancer cells by increasing intracellular ROS levels and depleting GSH levels","volume":"27","author":"Cui","year":"2022","journal-title":"Molecules"},{"issue":"19","key":"10.1016\/j.lfs.2023.122131_bb0265","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14194864","article-title":"Novel insights into redox-based mechanisms for auranofin-induced rapid cancer cell death","volume":"14","author":"Hatem","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.lfs.2023.122131_bb0270","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.181","article-title":"Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation","volume":"3","author":"Fokas","year":"2012","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.lfs.2023.122131_bb0275","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/abio.1997.2354","article-title":"Direct detection of 8-oxodeoxyguanosine and 8-oxoguanine by avidin and its analogues","volume":"255","author":"Struthers","year":"1998","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.lfs.2023.122131_bb0280","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0076-6879(10)74004-0","article-title":"Measuring the redox state of cellular peroxiredoxins by immunoblotting","volume":"474","author":"Cox","year":"2010","journal-title":"Methods Enzymol."},{"issue":"2","key":"10.1016\/j.lfs.2023.122131_bb0285","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.lfs.2023.122131_bb0290","first-page":"1473","article-title":"Synergy: a Python library for calculating, analyzing and visualizing drug combination synergy","volume":"37","author":"Wooten","year":"2021","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"2","key":"10.1016\/j.lfs.2023.122131_bb0295","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3892\/mmr.2014.2830","article-title":"Auranofin induces apoptosis and necrosis in HeLa cells via oxidative stress and glutathione depletion","volume":"11","author":"You","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.lfs.2023.122131_bb0300","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.sopen.2019.05.004","article-title":"Antineoplastic effects of auranofin in human pancreatic adenocarcinoma preclinical models","volume":"1","author":"Rios Perez","year":"2019","journal-title":"Surgery Open Sci."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2023.122131_bb0305","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.canlet.2012.01.016","article-title":"Oxidatively induced DNA damage: mechanisms, repair and disease","volume":"327","author":"Dizdaroglu","year":"2012","journal-title":"Cancer Lett."},{"issue":"9","key":"10.1016\/j.lfs.2023.122131_bb0310","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.tcb.2022.04.010","article-title":"DNA single-strand break repair and human genetic disease","volume":"32","author":"Caldecott","year":"2022","journal-title":"Trends Cell Biol."},{"issue":"12","key":"10.1016\/j.lfs.2023.122131_bb0315","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.molcel.2022.05.004","article-title":"Hallmarks of DNA replication stress","volume":"82","author":"Saxena","year":"2022","journal-title":"Mol. Cell"},{"issue":"12","key":"10.1016\/j.lfs.2023.122131_bb0320","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1089\/ars.2010.3466","article-title":"Base excision repair and lesion-dependent subpathways for repair of oxidative DNA damage","volume":"14","author":"Svilar","year":"2011","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"10.1016\/j.lfs.2023.122131_bb0325","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1083\/jcb.201312078","article-title":"DNA breaks and chromosomal aberrations arise when replication meets base excision repair","volume":"206","author":"Ensminger","year":"2014","journal-title":"J. Cell Biol."},{"issue":"10","key":"10.1016\/j.lfs.2023.122131_bb0330","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1021\/acschembio.5b00452","article-title":"Small molecule inhibitors of 8-oxoguanine DNA glycosylase-1 (OGG1)","volume":"10","author":"Donley","year":"2015","journal-title":"ACS Chem. Biol."},{"issue":"12","key":"10.1016\/j.lfs.2023.122131_bb0335","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1158\/0008-5472.CAN-09-3573","article-title":"Mechanism of radiosensitization by the Chk1\/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair","volume":"70","author":"Morgan","year":"2010","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.lfs.2023.122131_bb0340","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41594-022-00871-y","article-title":"Replication fork uncoupling causes nascent strand degradation and fork reversal","volume":"30","author":"Kavlashvili","year":"2023","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"6","key":"10.1016\/j.lfs.2023.122131_bb0345","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.febslet.2010.02.042","article-title":"Mitochondrial respiratory chain involvement in peroxiredoxin 3 oxidation by phenethyl isothiocyanate and auranofin","volume":"584","author":"Brown","year":"2010","journal-title":"FEBS Lett."},{"issue":"9","key":"10.1016\/j.lfs.2023.122131_bb0350","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41568-018-0034-3","article-title":"Targeting ATR in cancer","volume":"18","author":"Lecona","year":"2018","journal-title":"Nat. Rev. Cancer"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052300766X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052300766X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T10:59:40Z","timestamp":1736333980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002432052300766X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":70,"alternative-id":["S002432052300766X"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2023.122131","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic lethality between auranofin-induced oxidative DNA damage and ATR inhibition in cancer cells","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2023.122131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122131"}}